March 29 (Reuters) -
* ELI LILLY TO SIGN $2BN DEAL FOR AI DRUG DEVELOPMENT WITH
HONG KONG BIOTECH INSILICO MEDICINE - FT
* LILLY WILL ACQUIRE EXCLUSIVE RIGHTS TO SELL A GLP-1 DRUG
FOR DIABETES FROM INSILICO MEDICINE - FT
Source text: https://tinyurl.com/yrh4f2hz
Further company coverage: